All Stories

  1. MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors
  2. Differential GIP/GLP-1 intestinal cell distribution in diabetics’ yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length
  3. Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores
  4. GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass
  5. Vaccines for metabolic diseases: current perspectives
  6. Immunization Against Active Ghrelin Using Virus-Like Particles for Obesity Treatment